Case vs. control | Treatment vs. case | ||||||
---|---|---|---|---|---|---|---|
miRNA | log2 FC | Relevance to Neuropsychiatric disease | Ref | miRNA | log2FC | Relevance to Neuropsychiatric disease | Ref |
miR-1298 | 1.70 | NA |  | miR-7a-5p | −1.10 | NA |  |
miR-139-5p | 1.28 | May Marks sensitivity to stress | [22] | miR-181a-2-3p | 1.05 | Related to Cerebral cavernous malformations | [23] |
miR-139-3p | 1.41 | ↓by Nerve Growth Factor treatment | [24] | miR-200a-3p | 1.02 | Mediate antidepressant-like effects in stressed rat | [25] |
miR-34c-5p | 1.23 | ↓in blood&brain of MDD patients | miR-214-3p | −2.05 | adjusts Depressive-like Behaviors | [28] | |
miR-448-3p | 1.61 | NA |  | miR-32-3p | −1.24 | NA |  |
miR-204-5p | 1.07 | Suppressed by morphine | [29] | miR-6215 | 4.16 | NA | Â |
miR-10b-5p | −1.29 | Related to Parkinson disease | [30] | miR-653-5p | − 1.02 | NA |  |
miR-214-3p | 2.02 | adjusts Depressive-like Behaviors | [31] | miR-10b-5p | 1.36 | Related to Parkinson disease | [30] |